Enhancement of Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Interferon Alpha," Porcine reproductive and respiratory syndrome (PRRS) is a major problem for hog farmers worldwide. PRRS is caused by a virus which leads to reproductive failure in sows and respiratory problems in piglets and growing pigs. The PRRS virus spreads rapidly, leading to large economic losses for farmers and overall lower health for pigs. Currently, PRRS is controlled by inoculating pigs with modified live virus which stimulates the immune system of pigs against the PRRS virus. However, this therapy does not prevent PRRS virus infection and is limited by individual pigs ability to create a strong immune response against the vaccine. The current technology is a composition and method for use that enhances the immune response to PRRS vaccine for the purpose of improving the vaccines efficacy against the PRRS virus.One of the challenges with PRRS is that the PRRS virus is resistant to pigs natural immune response. The PRRS virus is able to hide from the natural defense system by being resistant to signals that alert the body of the viruses presence. Interferon-a is one such alert signal that PRRS virus fails to up-regulate. The current technology uses plasmids (or related technologies) to increase interferon-a production during administration of modified live virus vaccine. By doing so, interferon-a interacts with T cells to create virus specific interferon-? secreting cells. The result is a robust immune system response to the vaccine which should strengthen the immune systems ability to fight infection of PRRS virus.ApplicationsCan be used as a supplement to PRRS vaccines for swineHas broad application for hog farmers and veterinary clinicsBenefitsStrengthened immune system: In vivo application of interferon-a and modified live virus to pigs resulted in over 3x as many virus specific interferon-? secreting cells as modified live virus application alone Reduction in abortion/still births: Amount of PRRS virus specific interferon-? secreting cells is positively correlated with reduction of abortion/still births in sows"
Therapeutic Scheme for Human Basigin," Cancer researchers are focusing their efforts on identifying central pathways that trigger or enhance the invasiveness of tumor cells. One such target is EMMPRIN (Extracellular Matrix Metalloproteinase Inducer). It has been shown that EMMPRIN expression is linked to various cell signaling pathways that lead to an increase in tumor cell vascularization. Researchers are focusing efforts on elucidating the role of EMMPRIN in a number of disorders including cancer, arthritis, tissue repair and numerous inflammation-dependent diseases. DESCRIPTION/DETAILS Basigin is a member of the immunoglobulin superfamily thatis also known as EMMPRIN. Human basigin is expressed as two differentiallyspliced isoforms encoded by a single gene found on chromosome, renamedrespectively as basigin-1 and basigin-2. Attempts to demonstrate specifichemophilic on separate cells, or between soluble forms of recombinant basiginusing surface Plasmon resonance have not been successful, suggesting thatbasigin-2 cannot function as a receptor for itself. In order to identify possible receptors for soluble basiginligand, an affinity purification approach was employed. This approach resulted inthe labeling of several potential interacting proteins, and MALDI MS/MSsequencing of one of these proteins identified a novel isoform of human basigin(basigin-3).Immunoprecipitation studies using cell fractions revealed thatrBSG interacts with basigin-2 at the cell membrane, and subsequently interactswith the basigin-3 isoform within the cell. Small-interfering RNA (siRNA)knockdown of basigin-2 protein reduced, but did not eliminate, rBSG-mediatedERK activation in HESCs, suggesting that additional cell surface receptors forsoluble basigin may exist. Taken together, these results support the hypothesisthat basigin-2 can function as a receptor for soluble basigin and demonstratethat the hemophilic interactions between basigin proteins are not dependentupon glycosylation of the basigin ligand. It has also been shown that soluble EMMPRIN binds tomembrane-bound EMMPRIN and the bound complex is internalized presenting apotential means to deliver therapeutic compounds to the cell in a highlytargeted manner. A therapeutic scheme isproposed that aims to design EMMPRIN-conjugates designed to deliver cancertherapeutics in a targeted fashion.ApplicationsConjugation oftherapeutics to EMMPRIN increases specificity and targets cancers cells cancer (skin, bladder,breast); other inflammatory diseases (arthritis, endometriosis); Upregulationof inflammatory response.BenefitsIt is possible to design therapeutic agents directed toward human basigin. Possible therapeutic scheme to block tumor progressionor inflammation."
"Biosynthesis of Lantibiotics: In vitro semi-synthetic production methods for generation of industrial antibiotic, Lacticin 481"," This invention allows the engineering of semi-synthetic lantibiotics to a much larger extent than using typically practiced in vivo methods. The method is the first in vitro reconstruction lantibiotic photosynthesis and introduces non-proteinogenic amino acids.Lantibiotics are peptide-based compounds produced by bacteria that live on lactic acid. They are used as natural antibiotic food preservatives as an alternative to chemical reagents and have been used for half a century without any significant signs of lantibiotic-resistant bacteria popping up.Researchers at the University of Illinois have isolated and purified the LctM enzyme, responsible for synthesis of lacticin 481. This approach, the first in vitro reconstruction of lantibiotic biosynthesis, allows for lantibiotic engineering and opens the door to possible generations of new lantibiotics with greatly increased yields and improved activities.Applications Food preservationIndustrial enzyme productionBioengineering of novel lantibioticsBenefitsGreater Production Flexibility: In vitro methodology allows for lacticin 481 production using semi-synthetic substrates.Avoids Complications of In Vivo Production: In vitro methods avoid product cytotoxicity, degradation and bypasses many of the In vivo regualtory complications.Better Resistance Profile: Lantibiotics have been used for half a century in more than 40 countries without any significant signs of lantibiotic-resistant bacteria appearing.More Possibilities: The method works well with combinatorial techniques, increasing the number of substrates that can be used in production of lacticin 481. In addition, isolation of the LctM enzyme allows for more efficient synthesis with greater structural and functional tolerance of the biosynthetic pathway. "
"Gene Cluster Capable of Enabling the Biosynthesis of the Antimicrobial Compound, Rhizocticin In Bacillus subtilis"," Phosphonic and phosphinic acids are bioreactive compounds that have been used as antibiotics, antifungal agents, antimalarial drugs, and herbicides. Rhizocticins are naturally occurring phosphonates produced by Bacillus subtilus that have antifungal properties and interfere with the biosynthesis of the amino acid threonine. By varying the N-terminal amino acid group in the rhizocticin compound, it is possible to alter its biological activity. In particular, oligopeptides that are created by varying this amino acid could potentially allow enhanced capability for controlling selectivity for targeting particular organisms. As a result, compounds are less toxic to the host species and hold more promise for creating therapeutics. Despite the potential for making these types of compounds, organic synthesis has never been achieved due largely in part to the fact that the biosynthetic pathway has not been well understood. University of Illinois scientists have now identified the gene cluster responsible for biosynthesis of rhizocticin in B. subtilis, making biosynthesis of rhizocticin compounds possible.DetailsOriginal attempts to isolate and identify this unquie cluster failed, however, the genome of a specific strain of B. subtilis was sequenced and open reading frame locations were determined and annotated. Upon comparison with a non-rhizocticin-producing strain of B. subtilis, the rhizocticin biosynthetic gene cluster was able to be identified and isolated. There are more than 10 genes in the B. subtilis rhizocticin cluster. The biosynthetic pathway was proposed using sequence homology (similarity) for each of the genes. One particular gene in the cluster was identified by the inventors as being unique to this biosynthetic pathway. The cluster responsible for rhizocticin was verified by successfully inserting it into a non-producing strain of B. subtilis.ApplicationsPharmaceutical industry: Synthesis of biologically active compounds and analogs of rhizocticin.Production of novel oligopeptides with therapeutic propertiesAgricultural industry: HerbicideBenefitsThe identification of specific gene cluster for biosynthesis of rhizocticin allows:Specific synthesis of compounds;Control of biological activity of compounds; andControl of compound toxicity in mammals"
Therapeutic Agents for Treatment of Myotonic Dystrophy," Dr. Zimmerman's lab has developed a series of bioactive compounds for the treatment of myotonic dystrophy. The compounds disrupt the MBNL-(CUG) foci in vivo and partially rescue the missplicing of cTNT and IR mRNAs. These novel compounds, utilizing bisamidinium-based inhibitors, show a 1000-fold greater inhibition potency than a previous compound and are able to degrade the causative agent of the disease."
Pharmaceutical Compounds and Pathways from Actinobacteria, Dr. Metcalf and Dr. van der Donk from the University of Illinois have discovered 12 novel phosphonate natural products as well as the genes responsible for the biosynthesis of hundreds of additional compounds of other natural product classes. Phosphonic and phosphinic acids represent an underexploited group of bioactive compounds with great promise for the treatment of human disease.
A More Stable and Efficient Retroviral Gene Delivery Vector," This technology is a viral vector based on the murine leukemia virus (MLV), which has been favored for clinical gene therapy due to its preferential infectivity of human cell types. The original vector has been modified through the use of directed evolution targeting its protease (PR) gene, which has been found to produce increased stability for the viral vector. It is believed that this modification has the potential to be applied to all clinically-relevant viral vectors.Applications Clinical, such as delivery of gene therapy therapeuticsBiomedical Research by way of development of gene therapy therapeutics and general basic science research.BenefitsIncreased virus production.Increased infection efficiency.Increased safety (indirect benefit of decrease in required vector dose)."
Self-Assembled Nanometer Scale Lipid Bilayers for Drug Discovery and Therapeutic Delivery," One of the most challenging problems in biochemical science are studies that involve membranes, including small molecules and proteins which are associated with these cellular structures. Using designed amphipathic helical peptides, termed membrane scaffold proteins (MSPs), the Sligar laboratory has developed a simple and robust system that self-assembles phospholipids into soluble discoidal phospholipid bilayers of defined size (8-16 nm in diameter) termed Nanodiscs.Importantly, the same self-assembly process can be used to directly incorporate a variety of integral membrane proteins and small molecules into Nanodiscs. The result is a native-like environment that provides stability and full functionality for these integral membrane protein targets.Using MSPs of varying lengths, the size and composition of the Nanodiscs can also control the oligomerization state of incorporated targets. Additionally, the Sligar laboratory has demonstrated the usefulness of Nanodiscs in a variety of in vivo applications including imaging, delivery of therapeutics and in providing a naturalistic presentation of antigens for control of the immune response.ApplicationsAll classes of membrane proteins can be effectively solubilized using the Nanodisc technology, including; receptors, for example G-protein coupled receptors (GPCRs) which account for over 50 percent of drug targets; membrane bound enzymes such as the cytochromes P450 and in providing a precisely controlled membrane surface for control of biological processes such as blood coagulation and hemostasis.Additionally, since the Nanodisc incorporated target can be easily affixed to surfaces without loss of activity, the technology has direct application to uses in high-throughput screening modalities for drug discovery. All assay formats utilized for soluble targets are now applicable to those involving membranes and membrane proteins.Nanodiscs can be generated with natural or synthetic phospholipids, and can be formed pyrrogen free and suitable for in vivo therapeutic delivery allowing numerous applications in the fields of biologicals and small molecule drugs. The availability of lipid or covalent anchoring has also enabled use in the delivery of nucleic acid based therapeutics. "
Compounds That Selectively Induce Cancerous Cell Death in the G1 Phase of the Cell Cycle," Malignant melanoma is a cancer that is refractory to current chemotherapeutic treatments. The average survival time for patients is 6 months. This coupled with the alarming rise in incidence of melanoma (46,170 cases of in situ melanoma are expected to be newly diagnosed in 2005) warrants research into novel means to treat melanoma. Through the synthesis of a combinatorial library of potential proapoptotic agents, a novel class of small molecules (triphenylmethylamides, TPMAs) have been identified that are effective agents in killing melanoma cells, as well as other cancer cells. The majority of anticancer drugs operate through induction of cell cycle arrest and cell death in either the DNA synthesis (S) or mitosis (M) phase of the cell cycle. In contrast, these TPMAs, act in the G1 phase of the cell cycle. Many of the TPMAs are quite potent inducers of apoptotic death in melanoma cell lines (IC50 of 0.5 ?M), and importantly, some TPMAs are comparatively nontoxic to normal cells isolated from the bone marrow of healthy donors. Furthermore, the TPMAs dramatically reduce the level of active nuclear factor ?-B (NF?B) in the cell; NF?B is known to be constitutively active in melanoma, and this activity is critical for the proliferation of melanoma cells and their evasion of apoptosis. With regard to status of development, multiple generations of compounds have been tested and have shown efficacy with primary melanocytes, while these same compounds have shown to be largely non-toxic in initial rodent studies assessing changes in body weight and death. In addition, the National Cancer Institute?s 60-cell line screen has demonstrated activity of the compounds against a broad range of cancer types. Additional detailed information about this technology can be found in the recently published article: Synthesis and Identification of Small Molecules that Potently Induce Apoptosis in Melanoma Cells through G1 Cell Cycle Arrest (JACS 2005, 127, 8686-8696)ApplicationsChemotherapeutic treatment of Melanoma Chemotherapeutic treatment against other cancers, such as breast, colon, non-small cell lung carcinoma (NSCLC), etc.As a research reagent that arrests cells in G1. BenefitsPotent death inducers in melanoma cell lines with potencies in the 0.5 - 1.0 M rangeMarkedly less (8-12-fold) toxicity to the non-cancerous human bone marrow cellsNational Cancer Institute's 60-cell line screen demonstrated the compounds are quite active against a broad spectrum of cancers and confirmed the IC50 value of 600 nM against the UACC-62 melanoma cell line Initial animal testing suggests that mice can tolerate concentrations as high as 200 mg/kg Efficacy and water solubility are being increased as additional chemical modifications are made with later generation compounds "
A2Biosensor: Point-of-Care Ascorbic Acid Sensing for Anterior Penetrating Ocular Globe Injuries," Researchers have developed a point-of care device that can detect a penetrating ocular globe injury. Unlike current detection methods that require optical equipment like slip lamp biomicroscopes or other heavy machines, this technology allows for a faster, cheaper, and more mobile means of diagnosing certain eye injuries by making use of differential ascorbic acid concentrations in different parts of the eye."
Adaptive Acquisition and Reconstruction of Dynamic Magnetic Resonance Images," This invention is a new method for real time cardiac magnetic resonance (MR) imaging that produces high-spatial and temporal resolution motion movies of the beating heart non-invasively using a MRI scanner, even in the presence of breathing.MRI's use in the cardiovascular system has been limited. The basic challenge in cardiac MRI is posed by the dynamic motion of the imaged object during the MR data acquisition; unless special methods are adopted this produces unwanted artifacts in the reconstructed MR images in the presence of physiological motion. Also, instead of simply capturing ""snap-shot"" images one could reconstruct a dynamic movie of the moving object, providing further information of possible diagnostic value.Methods designed to deal with the motion of objects caused by the beating of the heart and respiration can be classified into three categories: 1) general fast imaging approaches 2) methods dealing with respiration-induces motion 3) methods dealing with cardiac-induced motion This technology improves on the existing methods in several ways.Does not require breath holding, and the drawbacks associated with it.Acquires data throughout the respiratory cycle and can reconstruct real-time images of a cardiac slice.Uses estimates of the respiration-induced motion to select the ideal set of MR data to be acquired and thus reduces the complexity of the reconstruction algorithm while improving the reconstruction quality.Uses a more accurate motion model for respiratory motion to produce still and moving images with fewer artifacts and wider applicability.Compensates for affine respiration-induce motion exactly. It can also optimize the MR acquisition and reconstruction process and can produce a motion-movie of the dynamically beating heart.Does not assume cardiac cyclicity, acquires data throughout the heartbeat and can produce real-time cardiac motion movies.  Explicitly models the effects of both cardiac and respiration-induced motion effects and hence overcome the drawbacks of these models.BenefitsEasy to integrate - This system can be combined with pre-existing static and dynamic MR imaging methods to make them insensitive to affine respiratory motion and tolerant of more general (non-affine) respiratory motion.Improved image quality - The quality of dynamic cardiac reconstructions obtainable by MR scanners is improved in current applications by reducing image artifacts. Also improves the MR imaging (MRI) of other organs (such as the liver) whose images are otherwise degraded by respiratory motion Extends clinical applications of cardiac MRI - Improves the spatial and temporal resolution and enables real time 3-D imaging.Helps more people - Increases the reach of cardiac MR to a larger set of patients by eliminating constraints imposed by breath-holding requirements."
Chemical Dyes as Contrast Agents for Optical Coherence Tomography (OCT)," These patent-pending optical contrast agents and molecular detection technologies were developed to enhance the ability of optical coherence tomography (OCT) to non-invasively map molecules in living specimens and diagnose disease where it starts. OCT utilizes low-coherence interferometry to measure the intensity of reflected or backscattered light to form images with micrometer resolution, is readily integrated with existing optical instrumentation and has application across a wide range of biological, medical, surgical, and non-biological specialties.  While the majority of contrast agents are engineered to alter the intensity of backscattered light, this class of near-infrared dyes was designed to transform spectral wavelength, making in situ and in vivo three-dimensional imaging a realityBenefits:Cell-specific targetingStrong light penetration of tissue at NIR wavelengthsHigh resolution imagesCompatible with existing dyes"
Method and Apparatus for Optical Imaging of Magnetic Particles," A spectral-domain magnetomotive optical coherence tomography apparatus, includes (a) a spectral-domain optical coherence tomography device, and (b) a magnet. The magnet is coupled with the optical coherence tomography device so that changes in the magnetic field are coordinated with collection of data by the optical coherence tomography device. This device may be used to examine a sample by spectral-domain magnetomotive optical coherence tomography, which includes examining the sample with a spectral-domain optical coherence tomography device, to collect optical coherence tomography data. The sample contains magnetic particles, and the magnetic particles are subjected to a changing magnetic field during the examining."
EMCCD Scintillation Camera for Low Energy X and Gamma Ray Imaging," A system that incorporates teachings of the present disclosure may include, for example, an ionizing radiation sensor having a first scintillator for generating photons from incoming ionizing radiation, an imaging intensifier for amplifying the photons, and an electron-multiplying charge-coupled device (EMCCD) coupled to the imaging intensifier for sensing the amplified photons generated by the imaging intensifier."
Group Refractive Index Reconstruction with Broadband Interferometric Confocal Microscopy," A system and method for microscale measurement and imaging of the group refractive index of a sample. The method utilizes a broadband confocal high-numerical aperture microscope embedded into an interferometer and a spectrometric means, whereby spectral interferograms are analyzed to compute optical path delay of the beam traversing the sample as the sample is translated through the focus of an interrogating light beam. A determination of group refractive index may serve to disambiguate phase ambiguity in a measurement of refractive index at a specified wavelength. Spatial resolution of object characterization in three dimensions is achieved by imaging the object from multiple viewpoints.Applicable to a variety of industries, this novel method measures Group Refractive Indices of biological tissues at the micron scale and can be applied to several optical imaging techniques, such as Optical Coherence Tomography and Confocal Microscopy. Although the method can be used for non-medical applications, its most beneficial application is in the diagnosis of cancerous cells. It allows for quickly measuring cells' organelles to indentify cancerous properties. Since this method does not require refraction, a larger variety of biological samples can be examined. Hardware is readily available for the application of this method, and the method can be applied to any optical imaging technique due to its universal math. "
"RF Coil for Improving Tuning Range, Cost and Maintaining Q"," A radio frequency (RF) coil comprising a plurality of electrically uninterrupted conductive legs, each leg having a first end and a second end, and at least one continuous conductor electrically connected to the first ends of the legs. Frequency tuning of the coil is achieved by translating, along the legs, an electrically continuous tuning band that includes a capacitor closed about the axis of the coil in proximity to the conductive legs. Maintaining electrical symmetry of the coil results in tuning ranges of at least 30 percent of the nominal value of the resonant frequency."
A Non-Invasive Blood Viscosity Measurement through Pulse Oximetry," A system that incorporates teachings of the present disclosure may include, for example, a sensor having a pulse oximeter sensor to measure an oxygen saturation level in a liquid, a magnetic source coupled to the pulse oximeter sensor, and a controller to control the pulse oximeter sensor and the magnetic source, and to measure a mechanical effect on the liquid responsive to the magnetic source applying a magnetic field to the liquid."
Auto-Calibrating Parallel MRI Technique with Distortion-Optimal Image Construction," This invention provides a new computational method for the formulation of magnetic resonance (MR) images to 1) reduce the scan time and complexity and 2) improve upon existing MRI methods. This is all accomplished while maintaining the integrity and functionality of other MRI methods.This invention describes the development of a computational method for the formulation of magnetic resonance (MR) images. It achieves this by utilizing data acquired by multiple receiver channels available on standard MRI scanners to 1) automatically identify the receiver characteristics without the need for additional data acquisition, 2) using the identification results to enable high quality imaging with fewer data samples than current methods and 3) improving upon the existing parallel MRI methods.This technology addresses two of the key issues/challenges (faster data retrieval and artifact free images) that MRI industry currently faces.ApplicationsNeurologicalMusculoskeletalCardiovascularOncologicalBenefitsReduced scan timeIncreased set of clinical applicationsReduced complexityBetter, high quality MR images (Artifact-Free Imaging)Software can be uploaded to existing machines"
Ultrasonic Biopsy Needle Shear Wave Imaging," An apparatus and method for estimating and imaging mechanical properties of biological tissues. The apparatus includes one or two ultrasound emitting devices (transducers) that first apply an acoustic radiation force to vibrationally displace a sphere embedded in the medium. Alternatively, a biopsy needle may be inserted into the medium and vibrated along its axis to generate shear waves. During and after vibration, ultrasound is again applied to image shear waves in the medium that propogate from the vibrating sphere or needle. By measuring the local wavelength of the shear waves, the shear modulus and viscous coefficient of the medium surrounding the vibrating element are estimated."
Biodegradable Implants and Matrices for Tissue/Bone Repair," These technologies provide biodegradable bone implants and artificial bone matrices for bony tissue repair. They encompass: (1) a method for creating organoapatite (artificial bone) matrices on surgical metal implants, as well as the matrix materials themselves, and (2) a biodegradable polymer matrix for use in bone tissue repair. Both types of material provide immediate tissue treatment or repair, while allowing and encouraging natural repair processes and cell growth to occur gradually. They degrade to biocompatible substances and/or naturally occurring metabolites.These technologies encompass a biodegradable, synthetic polymer for use as a tissue repair matrix, as well as a novel preparatory method for depositing organoapatites onto surgical metal alloys used in implants. The organoapatite matrix materials are included, as well. Both of these types of matrices are designed to promote natural tissue repair processes, following implantation, and to degrade, in situ, to physiologically and biochemically compatible compounds.Biodegradable Amphiphilic Polymer MatrixThis novel material is designed to have a lipophilic binding moiety covalently coupled to a hydrophilic tissue adhesion moiety via a divalent linker comprising either a natural metabolite or a polymer biodegradable into a metabolite. The preparation of these polymers, as well as their use in formulating implant matrices for tissue treatment and repair, is provided as well. Preferred polymers are prepared using a lipophilic alcohol or amine to initiate polymerization of one or more cyclic esters of hydroxyl acids. The resulting polyester is then covalently linked to a polyionic group, via one of several linker moieties. The composition of the matrices can vary from viscous liquid to molded solid, based on its chemical constituents and molecular weights. Specific, preferred matrices exhibit self-assembly, characteristic of liquid crystal compositions, and impart a unique matrix structure and function, with localized, ordered domains. Such domains possess temperature-dependent order, enabling liquid-solid transitions as a function of temperature (i.e., solidifying from a pre-implant liquid to a post-implant solid or liquid crystal). Polymers used in implant compositions degrade after implantation, providing a temporary template for cell growth and localized release of any contained bioactive additives. For tissue repair, the matrix is gradually replaced by endogenous tissue.In addition to being biodegradable, this innovative technology provides a unique matrix structure with localized domains. This property, coupled with its unique molecular structure affords significant potential for making implants with highly improved functionality. In addition, the liquid crystal nature of these matrices enables temperature-dependent ordering, i.e., the ability to change from liquid to solid following a change in temperature from slightly above-normal to normal body temperatures. The implant matrix composition can be used alone or can also contain an effective amount of a bioactive adjuvant (or cells) for tissue treatment/repair. The natural surfactant action of these amphiphilic, biodegradable matrices serves a tissue wetting/adhesive function; this, along with the ordered molecular arrangement, enhances cell growth and tissue regeneration at the implant site.Methodology for Deposition of Organoapatites onto Surgical Metal Alloys Organoapatites can be created by a serial treatment process, wherein a porous metal implant (typically a metal alloy) is immersed in a solution of a charged poly(amine)(s), followed by immersion in a second solution of a second, charged poly(amine)(s), whose charge is opposite that of the first poly(amine) (i.e., poly(lysine) (+) followed by poly(glutamate) (-)). The second polyamine solution may be the poly(amine) alone or in combination with apatite-forming constituents. These steps allow an insoluble, polyionic organic complex to form on the alloy, which serves as a type of scaffold for the subsequent, stable precipitation of apatites onto the coated alloy. The apatite-synthesizing step involves a ratio- and rate-controlled addition of solutions of calcium hydroxide and phosphoric acid to the final poly(amine) solution containing the metal alloy. Organoapatite precipitation occurs onto the alloy within minutes to hours. Following precipitation, the coated alloy is removed, rinsed twice, and vacuum dried, prior to use.Current methods aim to improve the rate of bone osseointegration in cementless systems, either by applying highly crystalline calcium phosphate to porous metal implants, or inserting bone allografts or reconstituted bone at the metal/bone interface. While inviting bone growth, the former method consists of a brittle, ceramic phase that is not fully resorbed and requires a high processing temperature that degrades the mechanical properties of the metal substrate. The latter methods, especially those using synthetic bone materials, are not sufficiently like natural bone in microstructure and/or composition, and bone growth rates are not effectively improved. This technology provides a method for growing fully (or at least partially) resorbable, synthetic bone on the surface of a porous metal implant that can be used to stimulate cellular activity and bone growth, with replacement (at least in part) by natural bone tissue. ApplicationsMedical: Orthopedic implants, prostheses, cellular/tissue repair materials (e.g., viscous liquid, gel, paste, moldable putty, or shape-retaining solid in molded form)Pharmaceutical R & D: Biodegradable polymer delivery systems and/or implantable matrices for targeted tissue repair/treatment agents (e.g., hormones, drugs, cells, bioengineered materials)BenefitsBiodegrades: Synthetic polymers and matrix materials undergo natural degradation to normal metabolites or precursors thereof, eliminating the need for surgical removal of implants.Promotes Tissue Growth and Healing: The amphiphilic nature of the polymer materials, as well as the unique matrix structure, promotes endogenous and/or exogenous cell/tissue adhesion and growth into the implant/matrix.Provides More Durable Implants: The organoapatites make bone-related implants stronger, longer-lasting, and more mechanically compatible.Decreases Likelihood of Extended Hospitalization: Enhanced growth and healing enables stress- and load-bearing to occur gradually, via a more natural process; biodegradation eliminates the need for additional hospitalization for surgical removal of implants.Lowers Costs: Decreased hospitalization durations will yield lower health care costs."
Integrated Portable Pneumatically Powered Ankle-Foot Orthosis," Below the knee muscle weakness, defined by weak dorsiflexor (shin) or plantarflexor (calf) muscle groups, can result from a variety of physical impairments or congenital abnormalities. Stroke, spinal cord injuries, polio and multiple sclerosis are among some of the physical injuries and congenital defects responsible for the condition. The largest complication from below the knee muscle weakness is abnormal gait, which when compensated for can lead to further complications in other muscles and joints.Ankle-foot-orthoses (AFOs) have been designed to assist afflicted individuals in walking and rehabilitation of the weakened muscle groups. Unfortunately, many commercially available AFOs are passive devices that cannot provide assistance during the propulsive phase of gait. Furthermore, these instruments are not capable of adapting to changes in walking conditions. Powered AFOs have been engineered to overcome these limitations but lack practicality in that they are commonly tethered to off-board power sources.This technology provides a non-tethered, portable pneumatic powered AFO that controls and assists propulsion of the foot as well as ankle motion using plantarflexor and dorsiflexor torque at the ankle joint.A custom-built pneumatic rotary actuator is located at the ankle joint. Torque generated by the actuator is used for both motion control of the foot and to provide supplemental torque for the individual during gait. Pressure regulators are used to manage the force produced by the rotary actuator and valves are used to direct the flow of fluid power to the actuator. Control and sensing of the actuator is accomplished through use of pressure and angle sensors and onboard electronics.ApplicationsThis device can be used to aid individuals afflicted with below the knee muscle weakness or impaired gait resulting from any number of physical injuries or congenital disabilities. Portability of the device permits the device to be used in a variety of locations. Applications include:Assistance in walking (including flexibility to walk outside)Relief from pain and discomfort during walkingRehabilitation of dorsiflexors and plantarflexors (possible from the patients personal residence)BenefitsThe portable pneumatic AFO is beneficial compared to passive AFOs in that it:Controls velocity of foot during initial contact to prevent foot-slapProvides torque at end of the stance for propulsionSupports the foot in the neutral, 90 degree position during swing to prevent foot-drop and allow free range of motion throughout the walking cycleEnables full customization of timing and magnitude of assistance through electronic and mechanical meansBenefits over other powered AFOs include:Portable, non-tethered power"
Miniaturized Walking Biological Machines," Dr. Bashir has developed a walking biological machine. This ""bio-bot"" can move spontaneously, and may be useful for sensing, information processing, transport, protein expression and actuation applications. "
Process for Making Modular Bioactuators,  Dr. Rashid Bashir has developed a process for manufacturing modular bioactuators. The process utilizes stereolithographic 3D printing to create injection molds for cell/hydrogel cultures and for skeletal scaffolds for the actuators. The resulting ring-like actuators can then be manually placed on the scaffold. This introduces a modular design that is customizable and transferable. These actuators are also triggered optogenetically and exhibit directional motion and 2D steering. 
Multiscale Porosity Biphasic Calcium Phosphate Scaffolds for Bone Regeneration,  Dr. Amy J. Wagoner Johnson from the University of IL has developed a scaffold for the use in bone regeneration procedures. The scaffold can be custom tailored to the individual patient through its additive manufacturing process. The scaffold has a variety of macropores and micropores. These differing pores influence capillarity and directionality of bone growth. This allows for predictability in how the bone will regenerate along the scaffold. These scaffolds have been shown to have enhanced weight bearing to current products. Efficacy of the scaffolds have been shown in in vivo pig studies. 
Drug Efficacy Prediction Tool,"University of Illinois and Mayo Clinic have come up with a software tool that will revolutionize the Artificial Intelligence Healthcare sector and the time when a computer might tell you what medicines to take is not far away. This invention can be used to predict efficacy of a drug on individual patients, predict future health complications and suggest patient specific therapy, and explain how a drug functions and why it doesn't respond.  Related publications include Data Driven Longitudinal Modelling and Prediction of Symptoms Dynamics in Major Depressive Disorder: Integrating Factor Graphs and Learning Methods and model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer"
Robotic Surgery with Haptic Feedback,Researchers from University of Illinois have advanced the field of robotic surgery by introducing haptic feedback based on the 3D point cloud reconstruction technique. The point cloud can be seen in the display and the doctor receives a feedback if the tip of the tool touches any unexpected region or with too great a force. The application has great potential since a small mistake can lead to death due to excessive bleeding.  
Mechanophore Embedded in PEG Gel and PDMS Networks,Dr. Li from the University of IL has developed PEG gel and PDMS networks that have mechanophoreâ€™s embedded in them and has developed a method of using Ultrasound technique to activate the mechanophores. The invention would be useful for non-invasive procedures and allow for stimulation of neurons by illuminating the mechanophore with ultrasound waves.
High Rare Earth Doped Optical Fiber and Heating Element Comprising Same,"Researchers from the University of Illinois and Clemson have developed highly rare earth doped optical fiber. This optical fiber . This optical fiber contains a high concentration of Yb. In the highly doped Yb fiber, At high rare earth (Yb) concentrations, Yb no long radiates light and optical pumping power is efficiently converted into thermal energy. The highly Yb doped fiber forms the basis of an efficient micro heating element. This micro heating element has the potential for use as a micro cauterization tool.   "
Apparatuses and Methods for Ear Biofilm Treatment by Microplasma Array Integrated Otoscope,"Drs. Eden, Boppart and Nguyen from the University of Illinois have developed a microplasma-integrated otoscope for non-invasive treatment of chronic ear infections. Compatible with commercial otoscopes, this technology enables microplasma treatment of antiobiotic-resistant inner ear biofilms associated with recurrent ear infections with a standard medical instrument.The otoscope specula are fitted with microchannels that deliver oxidizing microplasma to the biofilm in the middle ear, rendering it susceptible to antibiotic treatment that is otherwise ineffective. This method of treatment circumvents the need for invasive surgical procedures.Primary ApplicationOtology, Therapeutic Device"
A DNA-Based Diagnostic Test for the Identification of Individuals having the Mutation causing the Ectodermal Dysplasia (ED) Genetic Defect in Sheep," Researchers from the University of Illinois have identified a new inhibitor of the androgen receptor (AR), CPIC, that would be effective in the treatment of Castration Resistant Prostate Cancer (CRPC). CPIC targets a novel site on the full-length and truncated forms of the AR, present in the CRPC. Initial in vivo data has demonstrated that this new class of compounds is capable of inhibiting growth of prostate cancer cells. Furthermore, CPIC has shown to be 40x more potent against the truncated AR compared to current small molecules against the truncated AR."
Hydrophilic Nanocluster Contrast Agents for High Sensitivity Magnetic Resonance Imaging," Researchers from the University of Illinois have developed a new contrast agent for use with MRIs. The agent is made of super-paramagnetic iron oxide nanoparticles (SPIONs) with a special coating. This agent is an improvement over existing contrast agents and helps to increase the sensitivity of MRI scans. This is important, because it can define areas of damaged tissues which could go un-detected using currently available SPION-based contrast agents."
"Lipoprotein Nanoplatelets: Fluorescent, Zwitterionic Probes for Molecular and Cellular Imaging"," Dr. Smith has developed a new class of water-stable nanoplatelets encapsulated in lipoproteins. Nanoplatelets are bright single-molecule emitters, comparable to quantum dots, but with substantially narrower bandwidths. The nanoparticles retain their fluorescence after internalization in cells and thus are suitable for live-cell single-molecule imaging."
Simultaneous Identification of Mechanical and Optical Properties of Single Viruses using a Single Device,Professor Bahl from the University of Illinois at Urbana-Champaign has developed a device that can identify both optical and mechanical properties of single viruses with much higher throughput than current methods. This method takes us one step closer to identify the virus rather than just detect it. The rapid label-free identification of viruses can bring about a revolution in human health diagnostics and therapeutics.
DNA Sequencing Systems Using Nanoscale Field Effect Sensor Arrays," This invention is a novel approach to performing DNA sequencing-by-synthesis methodology that is anticipated to make DNA sequencing routine, highly accurate and affordable.The approach is a silicon-based field effect nanoscale sensor array using a sequence-by-synthesis methodology. PCR is performed locally in each pixel through the use of recently developed methods for heating fluid using a silicon field effect sensor, and then the amplified molecules in the pixel are detected in a label-free electrical manner where the added charge during the synthesis process is detected using the same thin-film SOI transistor.Cost is significantly reduced since the nucleotides do not need a fluorescent label, there is no need for gel electrophoresis, and the entire machinery of optical signal processing is unnecessary. In addition, since the silicon field effect sensors when used in a nanoscale dimension can be very sensitive and detect the charge from just a few molecules, it is quite feasible that the PCR amplification can be utilized with very few cycles. Reduction of PCR cycling would reduce the usage of costly reagents. The information retrieval can be scaled and the information obtained per unit time is maximized."
Coupled Heterogeneous Nanowire Nanoplate Planar Transistor Sensors for Giant Nernst Response," Researchers at the University of Illinois and Purdue University have designed new Ion-Sensitive Field Effect Transistors (ISFETs) for monitoring the pH of electrolytes with >10 V/pH Nernst response with a top-down CMOS compatible approach. This technology may be useful for biomedical applications like prton-based genome sequencers, pharmaceutical testing, and environmental toxin monitoring. "
New Way to Detect DNA Changes," Researchers from the University of Illinois have identified a new, cheaper and easier way to detect methylation (alterations) of DNA. By measuring the methylation of certain DNA sequences, doctors can predict the likelihood of cancers and other disorders. This early detection has the potential to save lives. "
DNAzyme Sensors for Soduim and Lithium,"Dr. Yi Lu has developed a point-of-contact device for the portable and affordable detection of molecules important in physiology and disease. This technology, based on highly specific nucleotide molecules known as DNAzymes, can detect physiological levels of metal ions such as sodium and lithium, which play an important role in bipolar disease. A modification of this technology, based on DNA molecules known as aptamers, can be adapted to detect the food adulterant melamine, which has resulted in death of thousands of infants and pets. Detection of these molecules can be performed at home with the commercially available glucose meters."
Using Organosilacyclobutanes to Form Carbon-Carbon Bonds without Toxic Byproducts," Traditional methods for forming carbon-carbon bonds between unsaturated moieties have a number of well-known difficulties. These cross-coupling reactions often require harsh conditions, use difficult-to-handle precursors, and result in poisonous byproducts. This invention uses known materials-organosilacyclobutanes or simple organosilanols-in a new way to avoid these problems. The process involves subjecting these materials to stereospecific cross-coupling reactions with organic electrophiles in the presence of an activator (either a fluoride source or oxygen-based nucleophile) and a palladium catalyst. Under these mild conditions, carbon-carbon bonds are formed without the toxic byproducts associated with traditional cross-coupling methods.This invention provides a mild, general and stereospecific method for the formation of carbon-carbon bonds between unsaturated moieties without the concomitant production of toxic byproducts. This new method addresses many of the difficulties associated with traditional cross-coupling techniques. By using organosilacyclobutanes or organosilanols, this process eliminates the need for processing in harsh conditions and using difficult-to-handle precursors. Most importantly, it eliminates the toxic byproducts that result from traditional methods. The cross-coupling begins with an organosilacyclobutane or organosilanol that is treated with a fluoride solution. After the initial exotherm subsides, the organic electrophile is added along with the palladium catalyst. The reactions times vary from 10 minutes to 7 hours at room temperature. The products then are isolated by removal of solvent and filtration through silica gel to remove salts and catalyst, followed by distillation. Occasionally filtration through a reverse phase (C-18) chromatography column is necessary to remove the byproduct. The products are formed in 65% to 93% of analytically pure material.Organosilacyclobutanes or organosilanols are a preferable material for cross-coupling reactions:Unlike magnesium and lithium agents, these materials are chemically inert and offer good functional-group compatibilities.Unlike zinc and aluminum agents, these materials are easy to prepare and generate in a geometrically defined form.Unlike tin agents, these materials do not result in toxic, heavy-metal byproducts.Unlike boron agents, these materials are not air sensitive and can be readily carried through synthetic sequences.Unlike previously employed organosilicon reagents, these materials have good reactivity.Unlike fluorosilanes, these materials can be processed at room temperature and are based on easy-to-handle precursors. Unlike orthosiliconates, these materials are not water sensitive and are highly reactive.BenefitsThe benefits of this invention accrue from its use of organosilacyclobutanes or organosilanols as the nucleophilic component in cross-coupling reactions. Unlike the materials used in traditional processes, these silicon-based moieties are chemically inert, have low molecular weight, are easy to introduce in a variety of organic structures, are stable to standard purification procedures, and can be activated by fluoride ions at room temperature. These features make the coupling process less complicated and less dangerous than traditional coupling methods.Simple: This invention eliminates the need for high-temperature processing conditions. Also, the silicon-based materials are easy to synthesize and purify.Low risk: This new process does not require the use of difficult-to-handle precursors traditionally needed for the formation of carbon-carbon bonds. Organosilacyclobutanes and organosilanols are chemically inert, while the fluoride source and palladium catalyst offer mild reaction conditions.Nontoxic: Unlike tin agents, silicon-based materials have a low molecular weight and do no yield heavy-metal byproducts. Thus, this process can be used in large-scale applications without concern for product contamination or toxic waste streams.Robust: Unlike boron agents, silicon-based materials are not air sensitive and can be carried through synthetic sequences readily."
Novel Use for Personal Glucose Meters," University of Illinois researchers have identified a new use for hand-held glucose meters to detect a variety of new disorders. By measuring the concentration of a certain cofactor, the glucose meter can correlate the reading to other non-diabetes diseases. "
<p>Production of Transgenic Pigs Containing the Gene Encoding Human Insulin-Like Growth Factor I (IGF-I) Under Control of the Bovine a-Lactalbumin Promoter and Regulatory Regions</p>," The present invention relates to animals that express exogenous growth factors in their milk, and in particular to pigs that express exogenous IGF-I in their milk. The present invention also relates to methods for increasing piglet weight gain and intestinal lactase activity. The present invention thus provides a method of facilitating piglet development and decreasing piglet mortality."
<p>Cell Encapsulation in Uniform Microcapsules with Built-In Cell Centering Mechanism</p>," A system that incorporates teachings of the present disclosure may include, for example, an apparatus having an outer nozzle operable to discharge an outer stream of a shell solution, and an inner nozzle operable to discharge an inner stream of a core solution intermixed with a plurality of materials. The outer stream can substantially surrounds the inner stream, thereby forming a combined stream. A plurality of capsules can be formed responsive to a force applied to the combined stream. At least a portion of the plurality of capsules are desirable capsules, each having a core encapsulated by a portion of the shell solution. The core can have at least one of the plurality of materials encapsulated by a portion of the core solution without protruding an outer surface of the portion of the shell solution."
<p>Preparation of Degradable Silica-Drug Conjugated Nanoparticle with Monodisperse Particle Sizes</p>," The invention provides a silica nanoparticle comprising a non-porous matrix of silicon-oxygen bonds, wherein the matrix comprises organic agents conjugated to silicon or oxygen atoms in the matrix, the organic agents are conjugated to the matrix through linker L groups, wherein the linker L comprises, for example, an ester, urea, thiourea, or thio ether group, and wherein the diameter of the nanoparticle is about 15 nm to about 200 nm. The invention also provides novel methods of making and using the silica nanoparticles."
<p>Nano-Antennas light up to Sequence DNA</p>,"Dr. Aksimentiev from the University of Illinois at Urbana-Champaign and researchers at TU Delft in The Netherlands have developed a plasmonic nanopore technology for DNA sequencing. One of the hurdles facing current nanopore-based DNA sequencing technologies is the inability to control DNA speeds passing through the pore. The group has developed nano-antennas that can focus high intensity light on the nanopore to create a ""hot-spot"" to trap and slow down DNA movement, which can help read long lengths of DNA more efficiently. "
<p>siRNA Delivery System for Inflammatory Diseases</p>," Dr. Jianjun Cheng and his research group have developed a system for delivering small interfering RNA (siRNA). siRNA can be used as a specific form of interference in the inflammation cascade that could be used to treat inflammatory diseases. The invention greatly enhances the delivery efficiency of the siRNA to the intended tissue.Related publication: Yin, L., Song, Z., Qu, Q., Kim, K. H., Zheng, N., Yao, C., Chaudhury, I., Tang, H., Gabrielson, N. P., Uckun, F. M. and Cheng, J. (2013), Supramolecular Self-Assembled Nanoparticles Mediate Oral Delivery of Therapeutic TNF-Î± siRNA against Systemic Inflammation. Angew. Chem. Int. Ed., 52: 5757â€“5761. doi:10.1002/anie.201209991"
<p>FRET Based High-Throughput Screening</p>," Advanced molecular imaging tools combined with investigative tools like biochemical and cell based assays have thepotential to unravel complex molecular processes. These tools combined with high throughput screening can significantly impact diagnostics for cancer screening and accelerate drug discovery. These inventions are two new Fluorescence Resonance Energy Transfer (FRET) biosensor pairs, one composed of two new colors, mOrange2 and mCherry and the other composed of a modified high-sensitive ECFP/YPet pair that can significantly enhance the dynamic range of a variety of biosensors. The ECFP/YPet can detect signaling events with high spatio-temporal resolutions which makes it an ideal readout indicator for high throughput screening.FRET technology and genetically encoded FRET biosensors are very useful in detecting active molecular events inlive cells with high temporal and spatial resolutions. FRET occurs when two flurophores are in proximity with the emission spectrum of the donoroverlapping with the excitation spectrum of the acceptor. To date, the most popular FRET pair is cyan and yellow fluorescent proteins (CFP and YFP).The new FRET biosensor pairs mOrange2/mCherry are proteins with different colors and spectrally distinctive from the CFP/YFP pair. This invention opens up the possibility of lighting two diagnostic biomarkers in the same cell e.g., cancer cells, thus providing a double criterion high-fidelity assay to differentiate cancer vs. normal cells.To provide proof-of-concept that mOrange2 and mCherry are suitable as novel FRET biosensors, they were operably linked to the protein recognition sequence of MMP-MT1. MMP-MT1 is an enzyme belonging to the matrix metalloproteinase family that has known roles in cancer metastasis. The basis of this assay is that when MT1-MMP is inactive, the mCherry and mOrange2 and positioned in proximity and favor a strong FRET between the two moieties. Indeed, in-vitro assays established that the mOrange/mCherry pair can serve as a reliable and sensitive indicator of the status of MT1-MMP activation and can potentially be applied to other biomarker assays.The ECFP/YPet pair provides a high-sensitive biosensor for the visualization of molecular hierarchy at different subcellular locations inlive cells. In-vitro assays revealedthat the ECFP/YPet pair exhibits significantly enhanced dynamic range of the MT1-MMP biosensor compared to currently available CFP/YFP FRET pairs. When quantified, the ECFP/YPet pair showed a 570% change (% change in basal level upon stimulation of MT1-MMP) when compared to only 90-100% in existing FRET pairs. The ECFP/YPet pair has also been successfully applied to other classes of proteins, like kinases, that are important therapeutic targets in human cancer.These and other genetically engineered biosensors can serve as a research tool to monitor different signaling cascades in live mammalian cells with high sensitivity. The developed MT1-MMP biosensor and potentially other protein biosensors can provide a powerful tool for the spatiotemporal imaging of protein functions in cancer development e.g. detection of circulating tumor cells (CTCs). Furthermore, these biosensors can serve as an excellent high-throughput reporting system forthe detection of cancer and the development of inhibitors for cancer therapeutics. BenefitsThe novel mOrange2/mCherry pair presents a method to simultaneously visualize two active signaling events in the same cell when combined with existing FRET pairsThe ECFP/YPet pair can serve as a high-sensitive biosensor with significantly enhanced dynamic ranges compared to existing CFP/YFP FRET pairs. The ECFP/Ypet pair can be operably linked to any protein recognition sequence to detect activity of that protein in live cells. The pair also includes a positively charged tag which allows 100% efficiency ofdetection. This invention demonstrates an ECFP/Ypet pair operably linked to MT1-MMP, a tumor metastasis biomarker, to accurately detect circulating tumor cells in blood samples. "
<p>Bio-Engineered Hyper-Functional Super Helicases</p>,"  Dr. Taekjip Ha has developed a bio-engineered, hyper-functional ""super"" helicase that is capable of unwinding 5000+ base pairs without stopping. The super helicase is designed such that the helicase cannot dissociate until the end of the DNA is encountered, making the processivity of the super helicase theoretically infinite in ideal conditions. Furthermore, it can exert forces in the range of 50-80pN which are currently the strongest helicase forces reported. This super helicase could provide a better alternative to helicases currently used in nanopore sequencing and isothermal PCR. Technology Benefits: Benefits over existing helicases: Natural Rep protein is a very poor helicase which can unwind DNA sequences as short as 18 base pairs (bp), and at very high concentrations, only up to 30-50 bp â€¢ Rep-X exhibits extremely enhanced DNA unwinding activity: it can unwind 5000+ bp without stopping â€¢ Rep-X is designed in a way that the helicase cannot physically dissociate until the end of the DNA is encountered. â€¢ Rep-X is an extremely strong protein, which cannot be stopped by forces up to 80 pN which is above the shearing force of double stranded DNA. By carefully controlling crosslinker length, and specific mutations sites that the crosslinkers target, other helicases can be stabilized in the specific conformation that gives rise to the super-active form (i.e. ""Helicase-X"")."
<p>Multiplexed Targeted Genome Engineering and Gene Activation</p>,"  Dr. Pablo Perez-Pinera from the University of Illinois has developed a multiplexable and universal nuclease-assisted vector integration system for rapid generation of gene knock outs using selection that does not require customized targeting vectors, thereby minimizing the cost and time frame needed for gene editing. Importantly, this system is capable of remodeling native mammalian genomes through integration of DNA, up to 50 kb, enabling rapid generation and screening of multigene knockouts from a single transfection. Furthermore, this method facilitates activation of genes by introduction of specific promoters that allows for genomic scale activation screens. Benefitsâ€¢ Minimizes cost and time for gene editingâ€¢ Multigene knockouts can be rapidly generatedâ€¢ Facile integration of large constructs up to 50 kbâ€¢ Introduces speci c promoters for genomic scale activation screens "
,"  Dr. Dipanjan Pan from the University of Illinois has developed a technology to enhance the bioavailability of poorly water soluble drugs. The technology involves coating such poorly water soluble drugs onto a carbon nanoparticle, cucurbituril (CB6) for controlled drug delivery and for improved antitumor activity in vivo. Benefitsâ€¢ Increases bioavailability of known low solubility drugs â€¢ Green carbon nanoparticles that reduces toxicityâ€¢ Theranostic applications  "
<p>Nanomaterial for Active Release of Molecules in Response to Increase in Internal PressureÂ </p>,Dr. Hyunjoon Kong from the University of IL has developed a MnO2 based nanosheets complexed with alginate encapsulated in PLGA. This formulation can be used for active release of molecules that uses internal pressure as a trigger in response to H2O2 exposure. This invention is a composition of matter that can be used as a method in drug delivery. The nanomaterial releases O2 gas in response to H2O2. This results in an increase in internal pressure and subsequent release of the active molecule. The advantage of this system is that it can be used for targeted delivery of active molecules at a controlled rate. This technology has application in theranostics as well as food industry. 
Ionizable Isotopic Labeling Reagents for Relative Quantification," Liquid chromatography/mass spectrometry (LC/MS) is increasingly being used for metabolic analysis due in part to its widespread availability and compatibility with biological samples. This invention provides ionizable, isotopic labeling reagents and labeling reaction products, answering the current need for relative quantification using mass spectrometry.Absolute quantification of an analyte relies upon the addition of an internal standard differing only in its isotopic form. However, it is impractical to add an isotopic standard for every compound when performing more comprehensive metabolic profiling. Relative quantification between samples is more amenable to analyzing broad classes of compounds, and it often provides very useful biological information.Heavy and light isotopic forms of methylacetimidate have been synthesized and used as labeling reagents for quantification of amine-containing molecules, such as biological samples. Heavy and light isotopic forms of formaldehyde and cholamine have also been synthesized and used independently as labeling reagents for quantification of amine-containing and carboxylic acid-containing molecules, such as these found in biological samples. Advantageously, the labeled end-products are positively charged under normal acidic conditions involving conventional liquid chromatography mass spectrometry (LC/MS) applications.This invention improves the precision of relative quantification by minimizing or negating errors associated with run-to-run irreproducibility. Such errors can arise from variations in mass spectrometric detection sensitivity, such as those caused by ionization suppression in electrospray, or from retention time differences between runs. The isotopic pair of labeled compounds co-elute within a single run. Therefore, they have identical retention times and are electrosprayed from identical solution conditions."
New 3D Gels for Cell Culture and Therapy," Researchers from the University of Illinois have created a new porus 3D gel. This gel can be prepared with a variety of natural or synthetic polymers and can also contain growth factors or other cellular signaling molecules to improve 3D cell culturing. This technology has the potential to be used in many novel techniques including stem cell therapy, organ and skin transplants as well as many research technologies and other medical processes. "
Optimally Tailored Raman Spectroscopic Probes for Ultrasensitive and Highly Multiplexed Assays," Embodiments of nanostructured, multilayered metal-dielectric particles suitable for use as Raman spectroscopic probes, as well as methods of designing, making and using such multilayered nanoparticles, and kits including the multilayered nanoparticles. The multilayered nanoparticles include alternating metal and dielectric layers and an outer dielectric shell. One or more of the dielectric layers may include a plurality of reporter molecules. Embodiments of the multilayered nanoparticles are suitable for detecting target analytes in a sample. Some embodiments of the multilayered nanoparticles are suitable for use in multiplexed assays, including assays for multiple target analytes having differing concentrations."
Lanthanide Chelate, Lanthanide chelates derived from diazacrown ethers having two ethyliminodiacetic acid side chains have increased ability to bind lanthanide ions.
Lantibiotic Screening Technique, Dr. van der Donk has developed a screening system for identifying novel antibiotics. The system uses phage display and has been optimized for lantibiotic natural products. The system also has utility for investigating interactions between lantibiotics and other peptides. Lantibiotics have complex structures which make them particularly stable under changing pH and protease exposure as well as possessing the ability to bind to bacterial cell wall targets. This makes them ideal for scaffolds for new antibiotic discovery that can combat the burgeoning problem of antibiotic resistance
New Synthetic Tumor Microenvironments," Researchers from the University of Illinois have developed a new synthetic tissue microenvironment that may give cancer researchers the next-best look at tumor growth and behavior. The 3D patterned vasculature tumor microenvironment is created by changing the flow rates of fluid channels and the structures are made of alginate that was mixed with breast cancer cells in the outer layer and macrophages on the inner layer. The 3D vascularization, a network of capillaries that carry drugs and other materials are created can go from straight, to snakelike, to any shape, that offers modelling for metastasis, because the vessel architecture can be tuned on the ï¬‚y. The technology accurately predicted the clinically measured EC50 of three drugs: Gefitinib, zoledronic acid, and RAC inhibitor. This quick process to create synthetic tumor microenvironments lends to tremendous potential such as model systems for high-throughput screening for drug efficacy, as well as flowable and vascularized lab-on-a-fiber platforms. Finally, biopsied cancer cells lends to personalized cancer treatments with this device that could realistically and quickly recreate microenvironments found across biology."